ArticleScientific reports2025
Evaluation of dimethylformamide (DMF) and Trehalose as cryoprotectants in African penguin Spheniscus demersus semen cryopreservation.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
We investigated the use of dimethylformamide (DMF), a permeating cryoprotectant, and its combination with trehalose, a non-permeating cryoprotectant, for the cryopreservation of African penguin (Spheniscus demersus) semen. Semen samples were cryopreserved using either 6% DMF alone (control group) or 3% DMF with 500 mM trehalose (T500 group). Post-thaw sperm quality was assessed based on motility parameters, viability, mitochondrial membrane potential, acrosomal integrity, apoptosis, and DNA fragmentation. Each treatment exhibited significant differences in specific aspects of post-thaw sperm quality. The control group showed higher total motility and mitochondrial membrane potential, whereas the T500 group demonstrated improved kinematic parameters (VCL, VSL, VAP, ALH, BCF), reduced apoptotic-like changes, less acrosomal damage and lower DNA fragmentation. Both treatments maintained viability, with a strong correlation between morphological and fluorescent viability assays. While the addition of trehalose did not enhance total motility, it conferred targeted cellular protection and improved motion dynamics potentially relevant to fertilization. These findings indicate that DMF and trehalose can improve post-thaw semen quality in African penguins, and that cryoprotectants may influence specific sperm traits differently across and within species.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.